CRISPR screens identify ACSL4 as a key regulator in macrophage activation and metabolic inflammation.
- DOI
- 10.1111/bph.70681
- Published
- 2026 Oct 16
- Container
- British journal of pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/bph.70681,
title = {CRISPR screens identify ACSL4 as a key regulator in macrophage activation and metabolic inflammation.},
author = {Lin Y and Jing D and Liu Y and Gao R and Zhao Q and Jiang X and Da H and Ren Y and Cao Q and Jiang J and Sun Y and Yang Y and Gao X},
year = {2026},
journal = {British journal of pharmacology},
doi = {10.1111/bph.70681},
url = {https://doi.org/10.1111/bph.70681}
}RIS
TY - JOUR TI - CRISPR screens identify ACSL4 as a key regulator in macrophage activation and metabolic inflammation. AU - Lin Y AU - Jing D AU - Liu Y AU - Gao R AU - Zhao Q AU - Jiang X AU - Da H AU - Ren Y AU - Cao Q AU - Jiang J AU - Sun Y AU - Yang Y AU - Gao X PY - 2026 JO - British journal of pharmacology DO - 10.1111/bph.70681 UR - https://doi.org/10.1111/bph.70681 ER -
APA
Y, L., D, J., Y, L., R, G., Q, Z., X, J., H, D., Y, R., Q, C., J, J., Y, S., Y, Y., & X, G. (2026). CRISPR screens identify ACSL4 as a key regulator in macrophage activation and metabolic inflammation.. British journal of pharmacology. https://doi.org/10.1111/bph.70681
Source records
- pubmed · retrieved 2026-11-10T04:53:47.473Z